Araris Biotech

Zürich, Switzerland

Araris Biotech is a biotechnology company that develops antibody-drug conjugates for efficient payload attachment.

Apr 2023

Grant

Biotechnology Health Care Medical Oncology

Top Investors

Schroders Capital 4BIO Capital b2venture redalpine VI Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Araris Biotech

Who are Araris Biotech's investors?

Araris Biotech's investors include Schroders Capital, 4BIO Capital, b2venture, redalpine, VI Partners.

Where is Araris Biotech headquartered?

Araris Biotech is headquartered in Zürich, Switzerland.

What does Araris Biotech do?

Araris Biotech is a biotechnology company that develops antibody-drug conjugates for efficient payload attachment.

What stage is Araris Biotech at?

Araris Biotech is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2023.

MLA

"Araris Biotech — Funding & Investors." VCBacked, April 28, 2023, https://www.vcbacked.co/company/araris-biotech. Accessed July 1, 2026.

APA

VCBacked. (2023). Araris Biotech — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/araris-biotech

Wikipedia (cite web)

{{cite web |title=Araris Biotech — Funding & Investors |url=https://www.vcbacked.co/company/araris-biotech |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K